Blue Wolf Capital Partners LLC agreed to acquire Seven manufacturing and development facilities of Recipharm AB (publ) on April 2, 2024. This acquisition includes Solna, Stängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets. The transaction is subject to customary regulatory approvals and is expected to close in Q4 2024.

Laura Sullivan, Jacob Traff and Nick Appleton, Jacqueline Clover from Kirkland & Ellis LLP and Kirkland & Ellis International LLP acted as legal advisors to Blue Wolf Capital Partners LLC. William Blair & Company, L.L.C. acted as financial advisor, Roschier Advokatbyrå Ab acted as legal advisor, PricewaterhouseCoopers AB, Investment Banking Arm and PricewaterhouseCoopers Sweden acted as financial advisor and accountant Recipharm AB (publ) in the transaction. IQVIA provided Commercial advice and ERM provided Environmental, Social and Governance advice to Recipharm AB (publ).